Clinical Research Directory
Browse clinical research sites, groups, and studies.
Real World Study of End-stage Liver Disease in China
Sponsor: Huashan Hospital
Summary
The aims of this study are exploring the current situation of end-stage liver disease in China, and the optimization of diagnosis and treatment. Liver cirrhosis often accompanied by a series of complications. Therefore, it is necessary to standardize the diagnosis and treatment of liver cirrhosis and its complications. End-stage liver disease mainly refers to the late stage of liver disease caused by various chronic liver damage. Its main feature is that liver function can not meet the physiological needs of human body. This study is a single-center, prospective and observational real-world study aimed at investigating and analyzing the current diagnosis and treatment of liver cirrhosis and end-stage liver disease in China.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
10000
Start Date
2019-09-01
Completion Date
2029-09-01
Last Updated
2019-07-30
Healthy Volunteers
Not specified
Conditions
Interventions
No intervation
No intervation
Locations (1)
HuaShan Hospital
Shanghai, Shanghai Municipality, China